Download PDF
Ernährung & Medizin 2022; 37(01): 9-13
DOI: 10.1055/a-1584-3327
Wissen

Möglichkeiten der Adipositastherapie in Deutschland

Christina Holzapfel
› Further Information
    Permissions and Reprints

Zusammenfassung

Adipositas ist eine der größten gesamtgesellschaftlichen Herausforderungen mit vielen Begleit- und Folgeerkrankungen. Voraussetzung für eine Gewichtsreduktion ist eine negative Energiebilanz, d. h. Menschen verbrauchen mehr Energie, als sie über Nahrungsmittel und Getränke zu sich nehmen. Im deutschen Gesundheitssystem ist Adipositas nicht als Erkrankung anerkannt. Es ist daher dringend nötig, Strukturen zu schaffen, die die Therapie verbessern und den Betroffenen den Zugang zu einem gesundheitsförderlichen Lebensstil erleichtern.



Publication History

Article published online:
15 March 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Mensink GB, Schienkiewitz A, Haftenberger M. et al. Übergewicht und Adipositas in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 786-794
    CrossrefPubMedGoogle Scholar
  • 2 Else Kröner-Fresenius-Zentrum für Ernährungsmedizin an der Technischen Universität München. Im Internet:. www.ekfz.tum.de Stand 28.02.2022
    PubMedGoogle Scholar
  • 3 Guh DP, Zhang W, Bansback N. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88
    CrossrefPubMedGoogle Scholar
  • 4 Gao M, Piernas C, Astbury NM. et al. Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol 2021; 9: 350-359
    CrossrefPubMedGoogle Scholar
  • 5 Johnston BC, Kanters S, Bandayrel K. et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 2014; 312: 923-933
    CrossrefPubMedGoogle Scholar
  • 6 Jenkins DJ, Wong JM, Kendall CW. et al. The effect of a plant-based low-carbohydrate (“Eco-Atkins”) diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med 2009; 169: 1046-1054
    CrossrefPubMedGoogle Scholar
  • 7 Shai I, Schwarzfuchs D, Henkin Y. et al. ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359: 229-241
    CrossrefPubMedGoogle Scholar
  • 8 Allaf M, Elghazaly H, Mohamed OG. et al. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2021; 1: CD013496
    PubMedGoogle Scholar
  • 9 Di Loreto C, Fanelli C, Lucidi P. et al. Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care 2005; 28: 1295-1302
    CrossrefPubMedGoogle Scholar
  • 10 wdv Gesellschaft für Medien & Kommunikation mbH & Co. OHG. Im Internet:. www.abnehmen-mit-genuss.de Stand 28.02.2022
    PubMedGoogle Scholar
  • 11 Jebb SA, Ahern AL, Olson AD  . et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011; 378: 1485-1492
    CrossrefPubMedGoogle Scholar
  • 12 Holzapfel C, Cresswell L, Ahern AL. et al. The challenge of a 2-year follow-up after intervention for weight loss in primary care. Int J Obes (Lond) 2014; 38: 806-811
    CrossrefPubMedGoogle Scholar
  • 13 Thomas JG, Bond DS, Raynor HA. et al. Comparison of smartphone-based behavioral obesity treatment with gold standard group treatment and control: A randomized trial. Obesity (Silver Spring) 2019; 27: 572-580
    CrossrefPubMedGoogle Scholar
  • 14 Villinger K, Wahl DR, Boeing H. et al. The effectiveness of app-based mobile interventions on nutrition behaviours and nutrition-related health outcomes: A systematic review and meta-analysis. Obes Rev 2019; 20: 1465-1484
    CrossrefPubMedGoogle Scholar
  • 15 Leslie WS, Taylor R, Harris L. et al. Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes (Lond) 2017; 41: 96-101
    CrossrefPubMedGoogle Scholar
  • 16 Lean MEJ, Leslie WS, Barnes AC. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 2018; 391: 541-551
    CrossrefPubMedGoogle Scholar
  • 17 Lean MEJ, Leslie WS, Barnes AC. et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019; 7: 344-355
    CrossrefPubMedGoogle Scholar
  • 18 Pi-Sunyer X, Astrup A, Fujioka K. et al. SCALE Obesity and Prediabetes NN8022–1839 Study Group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 2015; 373: 11-22
    CrossrefPubMedGoogle Scholar
  • 19 Lundgren JR, Janus C, Jensen SBK. et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med 2021; 384: 1719-1730
    CrossrefPubMedGoogle Scholar
  • 20 Wilding JPH, Batterham RL, Calanna S. et al. STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021; 384: 989
    CrossrefPubMedGoogle Scholar
  • 21 O’Brien PE, Hindle A, Brennan L. et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg 2019; 29: 3-14
    CrossrefPubMedGoogle Scholar